Statins (HMG-CoA reductase inhibitors), cholesterol and stroke

被引:1
|
作者
Marta-Moreno, J [1 ]
Echeandia, C [1 ]
Oliveros-Cid, A [1 ]
Figuerola, A [1 ]
Mola, S [1 ]
机构
[1] Hosp Miguel Servet, Serv Neurol, E-50009 Zaragoza, Spain
关键词
cerebral ischemia; cholesterol; HMG-CoA reductase; stroke;
D O I
10.33588/rn.27159.98262
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The HMG-CoA reductase inhibitors (known as statins) have been shown to reduce morbi-mortality of vascular origin, including transitory ischemic accidents and cerebral infarcts, in a large group of patients. The implications, both clinical and of costs, oblige us to consider analysis of the existing evidence and the answers to a number of questions arising in a field which has not yet received much attention from neurologists.
引用
收藏
页码:827 / 830
页数:4
相关论文
共 50 条
  • [41] HMG-CoA reductase inhibitors reduce adhesion of human monocytes to endothelial cells
    Teupser, D
    Bruegel, M
    Stein, O
    Stein, Y
    Thiery, J
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 289 (04) : 838 - 844
  • [42] Monotherapy with HMG-CoA reductase inhibitors and secondary prevention in coronary artery disease
    Rackley, CE
    CLINICAL CARDIOLOGY, 1996, 19 (09) : 683 - 689
  • [43] A QM/MM Evaluation of the Missing Step in the Reduction Mechanism of HMG-CoA by Human HMG-CoA Reductase
    Mihaljevic-Juric, Paula
    Sousa, Sergio F.
    PROCESSES, 2021, 9 (07)
  • [44] Advantages of lipid-lowering therapy in cerebral ischemia:: Role of HMG-CoA reductase inhibitors
    Gil-Núñez, AC
    Villanueva, JA
    CEREBROVASCULAR DISEASES, 2001, 11 : 85 - 95
  • [45] Stimulation of inflammatory responses in vitro and in vivo by lipophilic HMG-CoA reductase inhibitors
    Kiener, PA
    Davis, PM
    Murray, JL
    Youssef, S
    Rankin, BM
    Kowala, MK
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2001, 1 (01) : 105 - 118
  • [46] Synthesis and Biological Evaluation of Atorvastatin Derivatives as Novel HMG-CoA Reductase Inhibitors
    Tong, Jiayi
    Wang, Naxin
    Xiao, Hua
    LETTERS IN DRUG DESIGN & DISCOVERY, 2013, 10 (09) : 817 - 822
  • [47] Regulation of HMG-CoA synthase and HMG-CoA reductase by insulin and epidermal growth factor in HaCaT keratinocytes
    Harris, IR
    Höppner, H
    Siefken, W
    Farrell, AM
    Wittern, KP
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 114 (01) : 83 - 87
  • [48] Resveratrol attenuates the expression of HMG-CoA reductase mRNA in hamsters
    Cho, Il Jin
    Ahn, Ji Yun
    Kim, Suna
    Choi, Myung Sook
    Ha, Tae Youl
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 367 (01) : 190 - 194
  • [49] Determination of the Inhibitory Capacity on HMG-CoA Reductase Enzyme by Statins Using Molecular Docking Method
    Florescu, Cristina
    Rotaru, Luciana Teodora
    Varut, Renata Maria
    Grigorasi, Gabriela
    Kostici, Roxana
    Ciobanu, Daniela
    Cimpoesu, Diana
    REVISTA DE CHIMIE, 2018, 69 (04): : 837 - 839
  • [50] Synthesis of heterocyclic ring-fused analogs of HMG499 as novel degraders of HMG-CoA reductase that lower cholesterol
    Li, Xing-Zi
    Jiang, Shi-You
    Li, Guo-Qiang
    Jiang, Qian-Ru
    Li, Jue-Wan
    Li, Chen-Chen
    Han, Yu-Qin
    Song, Bao-Liang
    Ma, Xin-Ran
    Qi, Wei
    Qiu, Wen-Wei
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 236